Novel Sars-Cov-2 Pandemic Transmission With Ongoing Antiviral Therapies And Vaccine Design

1. Adhikari S.P., Meng S., Wu Y.J., Mao Y.P., Ye R.X., Wang Q.Z., Sun C., Sylvia S., Rozelle S., Raat H. et al.: Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infect. Dis. Poverty, 9, 29 (2020) Adhikari S.P. Meng S. Wu Y.J. Mao Y.P. Ye R.X. Wang Q.Z. Sun C. Sylvia S. Rozelle S. Raat H. et al Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infect. Dis. Poverty 9 29 202010.1186/s40249-020-00646-x707952132183901 Search in Google Scholar

2. Banerjee A., Kulcsar K., Misra V., Frieman M., Mossman K.: Bats and Coronaviruses. Viruses, 11, 41 (2019) Banerjee A. Kulcsar K. Misra V. Frieman M. Mossman K. Bats and Coronaviruses. Viruses 11 41 201910.3390/v11010041635654030634396 Search in Google Scholar

3. Baron Y.M.: Could changes in the airborne pollutant particulate matter acting as a viral vector have exerted selective pressure to cause COVID-19 evolution? Med. Hypotheses, 146, 110401–110401 (2021) Baron Y.M. Could changes in the airborne pollutant particulate matter acting as a viral vector have exerted selective pressure to cause COVID-19 evolution? Med. Hypotheses 146 110401 110401 202110.1016/j.mehy.2020.110401767951233303307 Search in Google Scholar

4. Callaway E.: COVID vaccine excitement builds as Moderna reports third positive result. Nature, 587, 337–338 (2020) Callaway E. COVID vaccine excitement builds as Moderna reports third positive result. Nature 587 337 338 202010.1038/d41586-020-03248-733199901 Search in Google Scholar

5. Chan J.F., Yuan S., Kok K.H., To K.K., Chu H., Yang J., Xing F., Liu J., Yip C.C., Poon R.W. et al.: A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet, 395, 514–523 (2020) Chan J.F. Yuan S. Kok K.H. To K.K. Chu H. Yang J. Xing F. Liu J. Yip C.C. Poon R.W. et al A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 395 514 523 202010.1016/S0140-6736(20)30154-9715928631986261 Search in Google Scholar

6. Chen H., Guo J., Wang C., Luo F., Yu X., Zhang W., Li J., Zhao D., Xu D., Gong Q. et al.: Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet, 395, 809–815 (2020) Chen H. Guo J. Wang C. Luo F. Yu X. Zhang W. Li J. Zhao D. Xu D. Gong Q. et al Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet 395 809 815 202010.1016/S0140-6736(20)30360-3715928132151335 Search in Google Scholar

7. Chen X., Yin Y.-H., Zhang M.-Y., Liu J.-Y., Li R., Qu Y.-Q.: Investigating the mechanism of Shu Feng Jie Du capsule for the treatment of novel Coronavirus pneumonia (COVID-19) based on network pharmacology. Int. J. Med. Sci. 17, 2511–2530 (2020) Chen X. Yin Y.-H. Zhang M.-Y. Liu J.-Y. Li R. Qu Y.-Q. Investigating the mechanism of Shu Feng Jie Du capsule for the treatment of novel Coronavirus pneumonia (COVID-19) based on network pharmacology. Int. J. Med. Sci. 17 2511 2530 202010.7150/ijms.46378753248233029094 Search in Google Scholar

8. Chen Y., Liu Q., Guo D.: Emerging coronaviruses: Genome structure, replication, and pathogenesis. J. Med. Virol. 92, 418–423 (2020) Chen Y. Liu Q. Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J. Med. Virol. 92 418 423 202010.1002/jmv.25681716704931967327 Search in Google Scholar

9. de Wit E., van Doremalen N., Falzarano D., Munster V.J.: SARS and MERS: recent insights into emerging coronaviruses. Nat. Rev. Microbiol. 14, 523–534 (2016) de Wit E. van Doremalen N. Falzarano D. Munster V.J. SARS and MERS: recent insights into emerging coronaviruses. Nat. Rev. Microbiol. 14 523 534 201610.1038/nrmicro.2016.81709782227344959 Search in Google Scholar

10. Diaz J.H.: Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19. J. Travel Med. 27 (2020). Diaz J.H. Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19. J. Travel Med. 27 202010.1093/jtm/taaa041718444532186711 Search in Google Scholar

11. Du L., He Y., Zhou Y., Liu S., Zheng B.-J., Jiang S.: The spike protein of SARS-CoV – a target for vaccine and therapeutic development. Nat. Rev. Microbiol. 7, 226–236 (2009) Du L. He Y. Zhou Y. Liu S. Zheng B.-J. Jiang S. The spike protein of SARS-CoV – a target for vaccine and therapeutic development. Nat. Rev. Microbiol. 7 226 236 200910.1038/nrmicro2090275077719198616 Search in Google Scholar

12. Gil C., Ginex T., Maestro I., Nozal V., Barrado-Gil L., Cuesta-Geijo M., Urquiza J., Ramírez D., Alonso C., Campillo N.E. et al.: COVID-19: Drug Targets and Potential Treatments. J. Med. Chem. 63, 12359–12386 (2020) Gil C. Ginex T. Maestro I. Nozal V. Barrado-Gil L. Cuesta-Geijo M. Urquiza J. Ramírez D. Alonso C. Campillo N.E. et al COVID-19: Drug Targets and Potential Treatments. J. Med. Chem. 63 12359 12386 202010.1021/acs.jmedchem.0c00606732306032511912 Search in Google Scholar

13. Guo Y.-R., Cao Q.-D., Hong Z.-S., Tan Y.-Y., Chen S.-D., Jin H.-J., Tan K.-S., Wang D.-Y., Yan Y.: The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Military Med. Res. 7, 11 (2020) Guo Y.-R. Cao Q.-D. Hong Z.-S. Tan Y.-Y. Chen S.-D. Jin H.-J. Tan K.-S. Wang D.-Y. Yan Y. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Military Med. Res. 7 11 202010.1186/s40779-020-00240-0706898432169119 Search in Google Scholar

14. Jayaweera M., Perera H., Gunawardana B., Manatunge J.: Transmission of COVID-19 virus by droplets and aerosols: A critical review on the unresolved dichotomy. Environ. Res. 188, 109819–109819 (2020) Jayaweera M. Perera H. Gunawardana B. Manatunge J. Transmission of COVID-19 virus by droplets and aerosols: A critical review on the unresolved dichotomy. Environ. Res. 188 109819 109819 202010.1016/j.envres.2020.109819729349532569870 Search in Google Scholar

15. Kannan S., Shaik Syed Ali P., Sheeza A., Hemalatha K.: COVID-19 (Novel Coronavirus 2019) – recent trends. Eur. Rev. Med. Pharmacol. Sci. 24, 2006–2011 (2020) Kannan S. Shaik Syed Ali P. Sheeza A. Hemalatha K. COVID-19 (Novel Coronavirus 2019) – recent trends. Eur. Rev. Med. Pharmacol. Sci. 24 2006 2011 2020 Search in Google Scholar

16. Latif A.A., Mukaratirwa S.: Zoonotic origins and animal hosts of coronaviruses causing human disease pandemics: A review. The Onderstepoort J. Vet. Res. 87, e1–e9 (2020) Latif A.A. Mukaratirwa S. Zoonotic origins and animal hosts of coronaviruses causing human disease pandemics: A review. The Onderstepoort J. Vet. Res. 87 e1 e9 202010.4102/ojvr.v87i1.1895775684833354975 Search in Google Scholar

17. Li X., Geng M., Peng Y., Meng L., Lu S.: Molecular immune pathogenesis and diagnosis of COVID-19. J. Pharm. Anal. 10, 102–108 (2020) Li X. Geng M. Peng Y. Meng L. Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. J. Pharm. Anal. 10 102 108 202010.1016/j.jpha.2020.03.001710408232282863 Search in Google Scholar

18. Lu C.W., Liu X.F., Jia Z.F.: 2019-nCoV transmission through the ocular surface must not be ignored. Lancet, 395, e39 (2020) Lu C.W. Liu X.F. Jia Z.F. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet 395 e39 202010.1016/S0140-6736(20)30313-5713355132035510 Search in Google Scholar

19. Lu R., Zhao X., Li J., Niu P., Yang B., Wu H., Wang W., Song H., Huang B., Zhu N. et al: Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet, 395, 565–574 (2020) Lu R. Zhao X. Li J. Niu P. Yang B. Wu H. Wang W. Song H. Huang B. Zhu N. et al Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395 565 574 202010.1016/S0140-6736(20)30251-8715908632007145 Search in Google Scholar

20. Mackenzie J.S., Smith D.W.: COVID-19: a novel zoonotic disease caused by a coronavirus from China: what we know and what we don’t. Microbiol. Australia, MA20013-MA20013 (2020) Mackenzie J.S. Smith D.W. COVID-19: a novel zoonotic disease caused by a coronavirus from China: what we know and what we don’t. Microbiol. Australia MA20013-MA20013 202010.1071/MA20013708648232226946 Search in Google Scholar

21. Miller A., Reandelar M.J., Fasciglione K., Roumenova V., Li Y., Otazu G.H.: Correlation between universal BCG vaccination policy and reduced mortality for COVID-19. medRxiv, 2020. 2003. 2024. 20042937 (2020) Miller A. Reandelar M.J. Fasciglione K. Roumenova V. Li Y. Otazu G.H. Correlation between universal BCG vaccination policy and reduced mortality for COVID-19. medRxiv 2020 2003. 2024. 20042937 202010.1101/2020.03.24.20042937 Search in Google Scholar

22. Peiris J.S.M., Guan Y., Yuen K.Y.: Severe acute respiratory syndrome. Nat. Med. 10, S88–S97 (2004) Peiris J.S.M. Guan Y. Yuen K.Y. Severe acute respiratory syndrome. Nat. Med. 10 S88 S97 200410.1002/9780470755952 Search in Google Scholar

23. Perlman S., Netland J.: Coronaviruses post-SARS: update on replication and pathogenesis. Nat. Rev. Microbiol. 7, 439–450 (2009) Perlman S. Netland J. Coronaviruses post-SARS: update on replication and pathogenesis. Nat. Rev. Microbiol. 7 439 450 200910.1038/nrmicro2147283009519430490 Search in Google Scholar

24. Rauch S., Jasny E., Schmidt K.E., Petsch B.: New Vaccine Technologies to Combat Outbreak Situations. Front. Immun. 9, 1963–1963 (2018) Rauch S. Jasny E. Schmidt K.E. Petsch B. New Vaccine Technologies to Combat Outbreak Situations. Front. Immun. 9 1963 1963 201810.3389/fimmu.2018.01963615654030283434 Search in Google Scholar

25. Roper R.L., Rehm K.E.: SARS vaccines: where are we? Expert Rev. Vaccines, 8, 887–898 (2009) Roper R.L. Rehm K.E. SARS vaccines: where are we? Expert Rev. Vaccines 8 887 898 200910.1586/erv.09.43710575419538115 Search in Google Scholar

26. Rothan H.A., Byrareddy S.N.: The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J. Autoimmun. 109, 102433 (2020) Rothan H.A. Byrareddy S.N. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J. Autoimmun. 109 102433 202010.1016/j.jaut.2020.102433712706732113704 Search in Google Scholar

27. Salvatori G., Luberto L., Maffei M., Aurisicchio L., Roscilli G., Palombo F., Marra E.: SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines. J. Transl. Med. 18, 222 (2020) Salvatori G. Luberto L. Maffei M. Aurisicchio L. Roscilli G. Palombo F. Marra E. SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines. J. Transl. Med. 18 222 202010.1186/s12967-020-02392-y726818532493510 Search in Google Scholar

28. Simmons G., Reeves J.D., Rennekamp A.J., Amberg S.M., Piefer A.J., Bates P.: Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proc. Natl. Acad. Sci. USA, 101, 4240–4245 (2004) Simmons G. Reeves J.D. Rennekamp A.J. Amberg S.M. Piefer A.J. Bates P. Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proc. Natl. Acad. Sci. USA 101 4240 4245 200410.1073/pnas.030644610138472515010527 Search in Google Scholar

29. Song Z., Xu Y., Bao L., Zhang L., Yu P., Qu Y., Zhu H., Zhao W., Han Y., Qin C.: From SARS to MERS, Thrusting Coronaviruses into the Spotlight. Viruses, 11, 59 (2019) Song Z. Xu Y. Bao L. Zhang L. Yu P. Qu Y. Zhu H. Zhao W. Han Y. Qin C. From SARS to MERS, Thrusting Coronaviruses into the Spotlight. Viruses 11 59 201910.3390/v11010059635715530646565 Search in Google Scholar

30. Su S., Wong G., Shi W., Liu J., Lai A.C.K., Zhou J., Liu W., Bi Y., Gao G.F.: Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses. Trends Microbiol. 24, 490–502 (2016) Su S. Wong G. Shi W. Liu J. Lai A.C.K. Zhou J. Liu W. Bi Y. Gao G.F. Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses. Trends Microbiol. 24 490 502 201610.1016/j.tim.2016.03.003712551127012512 Search in Google Scholar

31. https://clinicaltrials.gov/ Search in Google Scholar

32. Tok TT, G T.: Structures and Functions of Coronavirus Proteins: Molecular Modeling of Viral Nucleoprotein. Int. J. Virol. Infect. Dis., 2(1), 001–007 (2017) Tok TT G T. Structures and Functions of Coronavirus Proteins: Molecular Modeling of Viral Nucleoprotein. Int. J. Virol. Infect. Dis. 2(1), 001 007 2017 Search in Google Scholar

33. Tsai Y.-C., Lee C.-L., Yen H.-R., Chang Y.-S., Lin Y.-P., Huang S.-H., Lin C.-W.: Antiviral Action of Tryptanthrin Isolated from Strobilanthes cusia Leaf against Human Coronavirus NL63. Biomolecules, 10, 366 (2020) Tsai Y.-C. Lee C.-L. Yen H.-R. Chang Y.-S. Lin Y.-P. Huang S.-H. Lin C.-W. Antiviral Action of Tryptanthrin Isolated from Strobilanthes cusia Leaf against Human Coronavirus NL63. Biomolecules 10 366 202010.3390/biom10030366717527532120929 Search in Google Scholar

34. Velavan T.P., Meyer C.G.: The COVID-19 epidemic. Trop. Med. Int. Health, 25, 278–280 (2020) Velavan T.P. Meyer C.G. The COVID-19 epidemic. Trop. Med. Int. Health 25 278 280 202010.1111/tmi.13383716977032052514 Search in Google Scholar

35. Wan H., Cui J.-A., Yang G.-J.: Risk estimation and prediction of the transmission of coronavirus disease-2019 (COVID-19) in the mainland of China excluding Hubei province. Infect. Dis. Poverty, 9, 116 (2020) Wan H. Cui J.-A. Yang G.-J. Risk estimation and prediction of the transmission of coronavirus disease-2019 (COVID-19) in the mainland of China excluding Hubei province. Infect. Dis. Poverty 9 116 202010.1186/s40249-020-00683-6744385332831142 Search in Google Scholar

36. Wang M., Cao R., Zhang L., Yang X., Liu J., Xu M., Shi Z., Hu Z., Zhong W., Xiao G.: Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 30, 269–271 (2020) Wang M. Cao R. Zhang L. Yang X. Liu J. Xu M. Shi Z. Hu Z. Zhong W. Xiao G. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 30 269 271 202010.1038/s41422-020-0282-0705440832020029 Search in Google Scholar

37. Weiss S.R., Leibowitz J.L.: Coronavirus pathogenesis. Adv. Virus Res. 81, 85–164 (2011) Weiss S.R. Leibowitz J.L. Coronavirus pathogenesis. Adv. Virus Res 81 85 164 201110.1016/B978-0-12-385885-6.00009-2714960322094080 Search in Google Scholar

38. World Health O.: Coronavirus disease 2019 (COVID-19): situation report, 87. In Geneva: World Health Organization (2020) World Health O. Coronavirus disease 2019 (COVID-19): situation report, 87. In Geneva World Health Organization 2020 Search in Google Scholar

39. Worldometers.info: Worldometers. In. https://www.worldometers.info/coronavirus/ Worldometers.info: Worldometers In. https://www.worldometers.info/coronavirus/ Search in Google Scholar

40. Wu A., Peng Y., Huang B., Ding X., Wang X., Niu P., Meng J., Zhu Z., Zhang Z., Wang J. et al.: Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China. Cell Host Microbe, 27, 325–328 (2020) Wu A. Peng Y. Huang B. Ding X. Wang X. Niu P. Meng J. Zhu Z. Zhang Z. Wang J. et al Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China. Cell Host Microbe 27 325 328 202010.1016/j.chom.2020.02.001715451432035028 Search in Google Scholar

41. Yang Y., Peng F., Wang R., Yange M., Guan K., Jiang T., Xu G., Sun J., Chang C.: The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China. J. Autoimmun., 109, 102434 (2020) Yang Y. Peng F. Wang R. Yange M. Guan K. Jiang T. Xu G. Sun J. Chang C. The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China. J. Autoimmun. 109 102434 202010.1016/j.jaut.2020.102434712654432143990 Search in Google Scholar

42. Zhu F.C., Guan X.H., Li Y.H., Huang J.Y., Jiang T., Hou L.H., Li J.X., Yang B.F., Wang L., Wang W.J. et al.: Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet, 396, 479–488 (2020) Zhu F.C. Guan X.H. Li Y.H. Huang J.Y. Jiang T. Hou L.H. Li J.X. Yang B.F. Wang L. Wang W.J. et al Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet 396 479 488 202010.1016/S0140-6736(20)31605-6783685832702299 Search in Google Scholar

43. Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R. et al.: A Novel Coronavirus from Patients with Pneumonia in China, 2019. N. Engl. J. Med. 382, 727–733 (2020) Zhu N. Zhang D. Wang W. Li X. Yang B. Song J. Zhao X. Huang B. Shi W. Lu R. et al A Novel Coronavirus from Patients with Pneumonia in China, 2019. N. Engl. J. Med. 382 727 733 202010.1056/NEJMoa2001017709280331978945 Search in Google Scholar